Acidic leucine-rich nuclear phosphoprotein-32A expression contributes to adverse outcome in acute myeloid leukemia

BACKGROUND: Acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) is a novel regulator of histone H3 acetylation and promotes leukemogenesis in acute myeloid leukemia (AML). However, its prognostic value in AML remains unclear. METHODS: In this study, we evaluated the prognostic significance of AN...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Sai, Huang, Zhi, Ma, Chao, Luo, Lan, Li, Yan-Fen, Wu, Yong-Li, Ren, Yuan, Feng, Cong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186738/
https://www.ncbi.nlm.nih.gov/pubmed/32355789
http://dx.doi.org/10.21037/atm.2020.02.54

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186738/
https://www.ncbi.nlm.nih.gov/pubmed/32355789
http://dx.doi.org/10.21037/atm.2020.02.54

Ejemplares similares